News

Carvykti Approved for Multiple Myeloma

March 1, 2022

Read More »

Releuko, a New Biosimilar for Neupogen, Receives FDA Approval

March 1, 2022

Read More »

Brand Medications with Generic Alternatives Anticipated to be Approved in March

March 1, 2022

Read More »

Vonjo Granted Approval to Treat Rare Cancer

February 28, 2022

Read More »

Jardiance Receives New Heart Failure Indication

February 24, 2022

Read More »

First Restasis Generic Approved for Dry Eye

February 2, 2022

Read More »

XENOVIEW

January 28, 2022

Read More »

FDA Approves Expanded Solosec Indication

January 26, 2022

Read More »

Xarelto Approved to Treat and Prevent Blood Clots in Children

December 20, 2021

Read More »

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

Full Name(Required)

Email(Required)

Comment(Required)

Company Name(Required)

CAPTCHA